S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
NASDAQ:LNSR

LENSAR (LNSR) Stock Price, News & Analysis

$3.40
-0.36 (-9.58%)
(As of 03/28/2024 ET)
Today's Range
$3.36
$3.75
50-Day Range
$3.25
$5.00
52-Week Range
$1.80
$5.30
Volume
42,887 shs
Average Volume
58,814 shs
Market Capitalization
$38.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

LENSAR MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
135.5% Upside
$8.00 Price Target
Short Interest
Healthy
0.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.96mentions of LENSAR in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.04 out of 5 stars

Medical Sector

418th out of 939 stocks

Surgical & Medical Instruments Industry

50th out of 97 stocks

LNSR stock logo

About LENSAR Stock (NASDAQ:LNSR)

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

LNSR Stock Price History

LNSR Stock News Headlines

Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Analysts’ Top Healthcare Picks: 89bio (ETNB), UnitedHealth (UNH)
This consistently signaled gains of 453%... 610%... and even 1036%...
It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.
LENSAR Q4 2023 Earnings Preview
Navigating 6 Analyst Ratings For Viridian Therapeutics
LENSAR Stock (NASDAQ:LNSR), Short Interest Report
LENSAR Decline Means Insider Profits Down To US$42k
LENSAR's Earnings Outlook
Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
See More Headlines
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/04/2024
Today
3/28/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LNSR
Fax
N/A
Employees
110
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+135.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,380,000.00
Pretax Margin
-34.11%

Debt

Sales & Book Value

Annual Sales
$42.16 million
Book Value
$2.97 per share

Miscellaneous

Free Float
7,006,000
Market Cap
$38.73 million
Optionable
Optionable
Beta
0.53
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

LNSR Stock Analysis - Frequently Asked Questions

Should I buy or sell LENSAR stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for LENSAR in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" LNSR shares.
View LNSR analyst ratings
or view top-rated stocks.

What is LENSAR's stock price target for 2024?

1 analysts have issued 12-month target prices for LENSAR's shares. Their LNSR share price targets range from $8.00 to $8.00. On average, they expect the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 135.5% from the stock's current price.
View analysts price targets for LNSR
or view top-rated stocks among Wall Street analysts.

How have LNSR shares performed in 2024?

LENSAR's stock was trading at $3.51 at the beginning of 2024. Since then, LNSR stock has decreased by 3.2% and is now trading at $3.3970.
View the best growth stocks for 2024 here
.

Are investors shorting LENSAR?

LENSAR saw a decline in short interest in March. As of March 15th, there was short interest totaling 41,600 shares, a decline of 20.6% from the February 29th total of 52,400 shares. Based on an average daily trading volume, of 39,500 shares, the short-interest ratio is presently 1.1 days. Currently, 0.5% of the company's shares are sold short.
View LENSAR's Short Interest
.

When is LENSAR's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our LNSR earnings forecast
.

How were LENSAR's earnings last quarter?

LENSAR, Inc. (NASDAQ:LNSR) announced its quarterly earnings data on Monday, March, 4th. The company reported ($0.22) earnings per share for the quarter, meeting the consensus estimate of ($0.22). The company earned $12.11 million during the quarter. LENSAR had a negative trailing twelve-month return on equity of 40.53% and a negative net margin of 34.11%.

Who are LENSAR's major shareholders?

LENSAR's stock is owned by many different institutional and retail investors. Top institutional shareholders include DCF Advisers LLC (2.14%), Brandes Investment Partners LP (2.01%), Northern Trust Corp (0.30%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aimee S Weisner, Gary M Winer and Thomas R Staab II.
View institutional ownership trends
.

How do I buy shares of LENSAR?

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LNSR) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners